Post-transplant neurotoxicity: What role do calcineurin inhibitors actually play? [5]

American Journal of Neuroradiology

Volumn 27, Issue 8, 2006, Pages 1602-1603

  Sklar, Evelyn M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; TACROLIMUS;

ATAXIA; AUDITORY HALLUCINATION; BLOOD BRAIN BARRIER; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL BLINDNESS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; MENTAL HEALTH; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; SEIZURE; SIDE EFFECT; SPASTICITY; VASCULAR ENDOTHELIUM; VASOSPASM; VISUAL HALLUCINATION;

BRAIN; CALCINEURIN; CYCLOSPORINE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; NEUROTOXICITY SYNDROMES; RISK FACTORS; TACROLIMUS;

EID: 33748773675     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Palmer BF, Toto RD. Systemic neurologic toxicity induced by cyclosporine A in three renal transplant patients. Am J Kidney Dis 1991;18:116-21
2. Besenski N, Rumboldt Z, Emovon O, et al. Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am J Neuroradiol 2005;26:2282-89
3. Scheinman ST, Reinitz ER, Petro G, et al. Cyclosporine central neurotoxicity following renal transplantation: report of a case using magnetic resonance images. Transplantation 1990;49:215-16
4. Sheth TN, Ichise M, Kucharczyk W. Brain perfusion imaging in asymptomatic patients receiving cyclosporine. AJNR Am J Neuroradiol 1999;20:853-56
5. Jarosz JM, Howlett DC, Cox TCS, et al. Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Diagn Neuroradiol 1997;39:711-15